The global Burns Treatment Market is expected to garner a market value of USD 1.2 Billion in 2023 and is expected to accumulate a market value of USD 2.59 Billion by registering a CAGR of 8% in the forecast period 2023 to 2033. The market for Burns Treatment registered a CAGR of 5% in the historical period 2018 to 2022.
The burn treatment market is a segment of the healthcare industry that deals with the treatment of burn injuries. Burn injuries can range from minor to severe and can have a significant impact on a person's quality of life. The burn treatment market offers a range of products and services for the management and treatment of burn injuries, including wound dressings, topical agents, pain management products, and reconstructive surgery products.
| Report Attribute | Details |
|---|---|
| Expected Market Value (2023) | USD 1.2 Billion |
| Anticipated Forecast Value (2033) | USD 2.59 Billion |
| Projected Growth Rate (2023 to 2033) | 8% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to market research and competitive intelligence provider Future Market Insights- the market for Burns Treatment reflected a value of 5% during the historical period, 2018 to 2022.
A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering effective ways for Burns Treatment.
According to the National Center for Biotechnology Information, Approximately 486,000 patients require treatment for burns, and 40,000 require hospitalization within the United States each year. Nationally, 70% of patients who are burned receive burns that comprise less than 10% total body surface area (%TBSA), and 88% of all patients receive a less than 20% TBSA burn
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for Burns Treatment. In the years to come, increasing focus by government organizations and private agencies like WHO and pharmaceutical companies to create awareness of burn treatments is fuelling the market growth. Thus, the market for Burns Treatment is expected to register a CAGR of 8% in the forecast period 2023 to 2033.
Increased Prevalence of the Burn Injuries to Push the Market Growth
WHO reports that burns are a global public health problem, accounting for an estimated 180,000 deaths annually. The majority of these occur in low- and middle-income countries and almost two thirds occur in the WHO African and South-East Asia regions. In many high-income countries, burn death rates have been decreasing, and the rate of child deaths from burns is currently over 7 times higher in low- and middle-income countries than in high-income countries.
The rise in burn cases has fueled the need for advanced dressings like alginate, hydrogel, foam, hydrocolloid, collagen, etc. and biologics like skin grafts and traditional burn treatment products. With a variety of such products available, awareness of burn treatment among patients and healthcare professionals like surgeons, doctors, and nurses is growing.
For instance, in June 2022, The USA Food and Drug Administration approved StrataGraft for the treatment of deep partial thickness burns in adult patients. These burns are caused by direct contact with heat sources such as fire, hot surfaces, scalding water, or steam. StrataGraft offers healthcare professionals a new way to treat burn wounds and improve patient recovery by helping them return to their highest level of functionality and quality of life.
The treatment involves applying StrataGraft, made from human skin cells grown together to form a bi-layered construct, onto the burn. This can help reduce the need for skin grafting, where healthy skin is taken from the patient's body to cover the burn wound, leaving a new wound where the skin was removed. Over time, the patient's skin cells should grow to replace the lost skin cells, promoting healing.
Principal Consultant
Expensive Cost of Treatment to restrict Market Growth
The market is projected to get significantly affected by the challenging factors such as limited availability and high cost of advanced burn treatment products, lack of trained healthcare professionals in burn treatment, limited access to quality burn care facilities in developing countries, stringent government regulations for approval of burn treatment products, insufficient reimbursement for burn treatment procedures, competition from alternative treatments such as skin grafting and tissue engineering, risk of infections and other complications during burn wound treatment and so on.
Furthermore, lack of health remuneration policies, rise in cost, and side effects associated with certain treatments is expected to hinder the market growth.
Improvement in healthcare spending propelling growth of Burns Treatment in Asia Pacific
The Asia Pacific is expected to exhibit the significant growth rate of all regions over the forecast period, with a CAGR of 5% during the forecast period. The growth is owed to increased awareness, significant increases in healthcare spending, and a rising frequency of Burns Treatment Market in the region. Asia Pacific is an emerging market due to the increase in point of care approach to health & care. Increasing number of hospitals in India and China makes a promising market for the market worldwide.
India is expected to dominate the burn treatment market due to its large population and easy access to burn treatment products. The high population density increases the risk of cross-infection among patients, which is why top hospitals in India have equipped themselves with 30 isolated cubicles in ICUs and 10 private isolation beds to reduce the spread of infection. These factors make India a lucrative market for burn treatment products.
Technological Advancements Shaping Landscape for Burns Treatment in North America
North America is anticipated to acquire a market share of about 25% in the forecast period. This growth is attributable to the rising prevalence of the condition in the region. According to a 2018 report by the American Burn Association, over 300 children are treated in emergency rooms in the United States each day, with roughly two children dying from burn injuries. In the USA, children aged 16 and under account for roughly 26% of all burn center admissions. In addition, the National Center for Biotechnology Information (NCBI) estimates that 486,000 individuals are injured by fire each year. Thereby, the demand for burn treatment is anticipated to be in high demand as a result of a high rate of burns.
Furthermore, government initiatives and increase in the number of research partnerships are boosting the market growth across North America. The United States of America leads the regional market owing to the rising awareness about the condition and increasing number of populations with burn injuries is pushing the market growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Wound care dressings as an effective treatment to drive the market
According to the FMI analysis, alginate dressings are expected to grow with a CAGR of 7%. Alginate is a key component in various wound dressings such as hydrogels, films, wafers, foams, nanofibers, and topical preparations. The ability of alginate dressings to absorb excess wound fluid, create a moist environment, and reduce the risk of bacterial infections has driven the sales of these products. Alginate, a biopolymer, is widely used in biomedical applications due to its biocompatibility and non-toxicity, with wound healing being a particularly appealing use.
Second degree burns to take the lead and drive market growth
The second-degree burn segment is projected to grow at the fastest pace over the forecast period. Chronic wounds, including partial-thickness and full-thickness burns, take longer to heal and can cover more than 15% of the body. According to the FDA, around 40,000 people are hospitalized annually due to partial burns. The demand for biologics, like skin grafts and advanced dressings, is increasing to treat partial burns, driving the growth of the segment. Furthermore, favorable reimbursement policies in developed countries for second degree burn patients are expected to drive the segment's growth.
Key players in the Burns Treatment Market are Smith & Nephew, ConvaTec Group, B. Braun Melsungen AG, Molnlycke Health Care, Integra LifeSciences, Coloplast A/S, Paul Hartmann AG, 3M, Acelity L.P. Inc., and Medtronic among other global players.
| Report Attribute | Details |
|---|---|
| Market Value in 2023 | USD 1.2 Billion |
| Market Value in 2033 | USD 2.59 Billion |
| Growth Rate | CAGR of 8% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD Million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Treatment Type, Degree of Burn, Region |
| Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Middle East & Africa; Oceania |
| Key Countries Profiled | USA, Canada, Brazil, Argentina, Germany, United Kingdom, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, Association of Southeast Asian Nations, Gulf Cooperation Council, South Africa |
| Key Companies Profiled | Smith & Nephew; ConvaTec Group; B. Braun Melsungen AG; Molnlycke Health Care; Integra LifeSciences; Coloplast A/S; Paul Hartmann AG; 3M; Acelity L.P. Inc.; Medtronic |
| Customization | Available Upon Request |
The market’s net worth is expected to be USD 1.2 billion in 2023.
The projected market value of burns treatment is USD 2.59 billion by 2033.
The Asia Pacific is expected to expand at a CAGR of 5% over the forecast period.
Wound care dressings are preferred for treating burns.
Second degree burns account for considerable market share.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Treatment Type 5.1. Wound Care Dressings 5.1.1. Antimicrobial Dressings 5.1.2. Hydrocolloid Dressings 5.1.3. Hydrogel Dressings 5.1.4. Film Dressings 5.1.5. Foam Dressings 5.1.6. Alginate Dressings 5.2. Wound Care Therapy 5.2.1. Thermal Burn Therapy 5.2.2. Negative Pressure Wound Therapy 5.2.3. Ultrasound Therapy 5.2.4. Hyperbaric Oxygen Therapy 5.3. Medications 5.3.1. Burn Creams & Ointments 5.3.2. Anti-infective Drugs 5.3.3. Painkillers & Anti-anxiety Medications 5.3.4. IV-Fluids & Therapeutic Peptide Nutrition 5.4. Surgeries 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Degree of Burn 6.1. First-degree Burns 6.2. Second-degree Burns 6.3. Third-degree Burns 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. North America 7.2. Latin America 7.3. Europe 7.4. South Asia 7.5. East Asia 7.6. Oceania 7.7. MEA 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Key Countries Market Analysis 16. Market Structure Analysis 17. Competition Analysis 17.1. MediWound Germany GmbH 17.2. Kaken Pharmaceutical Co., Ltd. 17.3. Kerecis 17.4. Mallinckrodt Pharmaceuticals 17.5. Avita Medical 17.6. Vericel Corporation 17.7. KeraNetics 17.8. Integra LifeSciences Corporation 17.9. PolyNovo 17.10. Medline Industries 17.11. Anika Therapeutics, Inc. 17.12. ACell, Inc. 17.13. Amryt Pharma 17.14. CUTISS AG 17.15. Skingenix 17.16. RenovaCare 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Burns Treatment Market
